The oncogenic RAS2 super(val19) mutation locks respiration, independently of PKA, in a mode prone to generate ROS

• Published in: The EMBO journal Vol. 22; no. 13; pp. 3337 - 3345
• Main Authors: Hlavata, L, Aguilaniu, H, Pichova, A, Nystroem, T
• Format: Journal Article
• Language: English
• Published: 01.07.2003
• ISSN: 0261-4189

The RAS2 super(val19) allele, which renders the cAMP-PKA pathway constitutively active and decreases the replicative life-span of yeast cells, is demonstrated to increase production of reactive oxygen species (ROS) and to elevate oxidative protein damage. Mito chondrial respiration in the mutant is locked in a non- phosphorylating mode prone to generate ROS but this phenotype is not linked to a constitutively active PKA pathway. In contrast, providing RAS2 super(val19) cells with the mammalian uncoupling protein UCP1 restores phosphorylating respiration and reduces ROS levels, but does not correct for PKA-dependent defects. Thus, the RAS2 super(val19) allele acts like a double-edged sword with respect to oxidation management: (i) it diminishes expression of STRE element genes required for oxidative stress defenses in a PKA-dependent fashion, and (ii) it affects endogenous ROS production and the respiratory state in a PKA-independent way. The effect of the oncogenic RAS allele on the replicative life-span is primarily asserted via the PKA-dependent pathway since Pde2p, but not UCP1, overproduction suppressed premature aging of the RAS2 super(val19) mutant.